Uterine sarcoma 2008

Current Oncology Reports

Volumn 10, Issue 6, 2008, Pages 512-518

  Lin, Jeff F ^a   Slomovitz, Brian M ^a  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IMATINIB; LETROZOLE; MESNA; METHOTREXATE; PACLITAXEL; PLATINUM COMPLEX; PROGESTERONE DERIVATIVE; SUNITINIB; VINCRISTINE;

ADENOSARCOMA; ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CARCINOSARCOMA; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG EFFICACY; ENDOMETRIUM BIOPSY; ENDOMETRIUM SARCOMA; HUMAN; HYSTERECTOMY; LEIOMYOSARCOMA; LYMPH NODE DISSECTION; METASTASIS POTENTIAL; MONOTHERAPY; MYOMECTOMY; OVERALL SURVIVAL; PERITONEUM LAVAGE; PROGNOSIS; REVIEW; SALPINGOOOPHORECTOMY; UTERUS SARCOMA; VAGINA BLEEDING;

CARCINOSARCOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LEIOMYOSARCOMA; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; RECURRENCE; RESEARCH DESIGN; SARCOMA; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 58649099573     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0077-9     Document Type: Review

References (45)

1. Brooks S, Zhan M, Cote T: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004, 93: 204-208.
2. Platz CE, Benda JA: Female genital tract cancer. Cancer 1995, 75(1 Suppl): 270-294.
3. McMeekin D: Sarcoma of the Uterus. In: Clinical Gynecologic Oncology, end 7. Edited by DiSaia P, Creasman W. Philadelphia: Elsevier; 2007:185-199.
4. Silverberg S, Kurman R: Tumors of the uterine corpus and gestational trophoblastic disease. In: Atlas of Tumor Pathology. Edited by Rosai J, Sobin LH. Washington DC: Armed Forces Institute of Pathology; 1992.
5. Bansal N, Herzog T, Burke W, et al.: The utility of preoperative endometrial sampling for the detection of uterine sarcomas. Gynecol Oncol 2008, 110: 43-48.
6. Memarzadeh S, Mundt A, Berek J: Classification, clinical manifestations, and staging of uterine sarcoma. Available at http://www.uptodate.com/ patients/cotent/topic.do?topicKey=:_Md99fpsgNAsSR0. Accessed August 2008.
7. Ferrer F, Sabater S, Farrus B, et al.: Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Grup Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys 1999, 44: 47-52.
8. Hornback NB, Omura G, Major FJ: Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 1986, 12: 2127-2130.
9. Knocke TH, Kucera H, Dorfler D, et al.: Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 1998, 83: 1972-1979.
10. Molpus K, Redlin-Frazier S, Reed G, et al.: Postoperative pelvic irradiation in early stage uterine mixed mullerian tumors. Eur J Gynaecol Oncol 1998, 19: 541-546.
11. Moskovic E, MacSweeney E, Law M, Price A: Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients. Br J Radiol 1993, 66: 1009-1015.
12. Reed NS, Mangioni C, Malmstrom H, et al.: First results of a randomized trial comparing radiotherapy versus observation postoperatively in patients with uterine sarcomas. An EORTC-GCG Study [abstract]. Int J Gynecol Cancer 2003, 13(Suppl 11): 4.
13. Salazar O, BAnfiglio T, Patten S, et al.: Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 1978, 42: 1161-1170.
14. Soumarova R, Horova H, Seneklova Z, et al.: Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet 2002, 266: 92-95.
15. Weitmann H, Knocke TH, Kucera H, Potter R: Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001, 49: 739-748.
16. Kempson R, BCri W: Uterine sarcomas: classification, diagnosis and prognosis. Hum Pathol 1970, 1: 331-349.
17. DiSaia PJ, Pecorelli S: Gynecological sarcomas. Semin Surg Oncol 1995, 10: 369-373.
18. Kahanpaa KV, WahlsArom T, Grohn P, et al.: Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 1986, 67: 417-424.
19. Sherman ME, Devesa SS: Analysis of racial differences in incidence, survival and mortality for malignant tumors of the uterine corpus. Cancer 2003, 98: 176-186.
20. Gorai I, Yanagibashi T, Taki A, et al.: Uterine carcinosarcoma is derived from a single stem cell: An in vitro study. Int J Cancer 1997, 72: 821-827.
21. Zelmanowicz A, Hildesheim A, Sherman ME, et al.: Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998, 69: 253-257.
22. Sartori E, Bazzurini L, Gadducci A, et al.: Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study. Gynecol Oncol 1997, 67: 70-75.
23. Greer B, Koh W, Abu-Rustum N, et al.: Uterine Neoplasms. Available at http://www.nccn.org/professionals/physician_gls/PDF/uterine.pdf. Accessed August 2008.
24. Hoskins P, Le N: Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus. Int J Gynecol Cancer 2008 (Epub ahead of print).
25. Huang GS, Chiu LG, Gebb JS, et al.: Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 2007, 107: 513-517.
26. Gerszten K, Faul C, Kounelis S, et al.: The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 1998, 68: 8-13.
27. Omura GA, Blessing JA, Major F: A randomized clinical trial of adjuvant adriamycin in uterine sarcoma: A Gynecologic Oncology Group Study. J Clin Oncol 1985, 3: 1240-1245.
28. Resnik E, Chambers S, Carcangiu M: A phase II study of etoposide, cisplatin and doxorubicin chemotherapy in mixed mullerian tumors (MMT) of the uterus. Gynecol Oncol 1995, 56: 370-375.
29. Homesley HD, Filiaci V, Markman M, et al.: Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group Study. J Clin Oncol 2007, 25: 526-531.
30. O'Connor D, Norris H: Mitotically active leiomyomas of the uterus. Hum Pathol 1990, 21: 223-227.
31. Bell SW, Kempson RL, Hendrickson MR: Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994, 18: 535-558.
32. Evans HL, Chawla SP, Simpson C, Finn KP: Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988, 62: 2239-2247.
33. Parker W, Fu Y, Berek J: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994, 83: 414-418.
34. Juang CM, Yen MS, Horng HC, et al.: Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma. Eur J Gynaecol Oncol 2006, 27: 370-374.
35. Gadducci A, LandonA F, Sartori E: Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996, 62: 25-32.
36. Peters W, Howard D, Andersen W, Figge D: Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 1994, 83: 1015-1020.
37. Kapp D, Shin J, Chan J: Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: Emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008, 112: 820-830.
38. Fleming G: Gemcitabine/docetaxel - welcome to a new standard. Gynecol Oncol 2008, 109: 313-315.
39. Hensley ML, Blessing JA, Degeest K, et al.: Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study. Gynecol Oncol 2008, 109: 323-328.
40. Hensley ML, Blessing JA, Mannel R, Rose PG: Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial. Gynecologic Oncology 2008, 109: 329-334.
41. Leath C, Huh W, Hyde J, et al.: A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007, 105: 630-634.
42. Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982, 50: 2170-2182.
43. Oliva E, Clement P, YoAng R: Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 2000, 7: 257-281.
44. Gadducci A, Sartori E, Landoni F, et al.: Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996, 63: 247-253.
45. Verschraegen C, Vasuratna A, Edwards C, et al.: Clinicopathologic analysis of mullerian adenosarcoma: The M.D. Anderson Cancer Center experience. Oncol Rep 1998, 5: 939-944.